1. Home
  2. CCO vs PRTC Comparison

CCO vs PRTC Comparison

Compare CCO & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCO
  • PRTC
  • Stock Information
  • Founded
  • CCO 1995
  • PRTC 2015
  • Country
  • CCO United States
  • PRTC United States
  • Employees
  • CCO N/A
  • PRTC N/A
  • Industry
  • CCO Advertising
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCO Consumer Discretionary
  • PRTC Health Care
  • Exchange
  • CCO Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • CCO 472.0M
  • PRTC 432.3M
  • IPO Year
  • CCO 2005
  • PRTC N/A
  • Fundamental
  • Price
  • CCO $1.07
  • PRTC $18.50
  • Analyst Decision
  • CCO Buy
  • PRTC Buy
  • Analyst Count
  • CCO 4
  • PRTC 1
  • Target Price
  • CCO $1.88
  • PRTC $45.00
  • AVG Volume (30 Days)
  • CCO 1.8M
  • PRTC 3.2K
  • Earning Date
  • CCO 05-01-2025
  • PRTC 04-30-2025
  • Dividend Yield
  • CCO N/A
  • PRTC N/A
  • EPS Growth
  • CCO N/A
  • PRTC N/A
  • EPS
  • CCO N/A
  • PRTC 0.21
  • Revenue
  • CCO $1,512,570,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • CCO $5.10
  • PRTC $35.98
  • Revenue Next Year
  • CCO $3.29
  • PRTC $115.38
  • P/E Ratio
  • CCO N/A
  • PRTC $8.24
  • Revenue Growth
  • CCO 14.28
  • PRTC 44.98
  • 52 Week Low
  • CCO $0.81
  • PRTC $13.30
  • 52 Week High
  • CCO $1.88
  • PRTC $32.98
  • Technical
  • Relative Strength Index (RSI)
  • CCO 44.57
  • PRTC 58.17
  • Support Level
  • CCO $1.14
  • PRTC $17.80
  • Resistance Level
  • CCO $1.10
  • PRTC $19.17
  • Average True Range (ATR)
  • CCO 0.06
  • PRTC 0.48
  • MACD
  • CCO -0.01
  • PRTC 0.13
  • Stochastic Oscillator
  • CCO 13.89
  • PRTC 74.72

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: